- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05962372
Essai clinique diététique culturellement adapté en RP (PRECISION)
Essai clinique alimentaire adapté à la culture en RP : évaluation à Porto Rico d'une intervention durable culturellement informée pour une nutrition optimale (PRECISION)
This project will determine whether a diet culturally adapted to adults in Puerto Rico can effectively decrease cardiometabolic risk factors. This will help define a culturally-appropriate, feasible, and sustainable diet intervention aimed at reducing cardiovascular, type 2 diabetes, and obesity outcomes.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This intervention will culturally tailor a diet to the adult population in Puerto Rico based on staple foods as well as culturally appropriate strategies to reduce cardiometabolic risk factors. Based on preliminary results from studies on the island, investigators will conduct a 24-month, 2-arm intervention among 250-350 adults (125-175 per arm) ages 30-65 living in Puerto Rico with at least 1 of 5 cardiometabolic risk factors. The two arms are (1) intervention group with culturally-tailored portion-control Mediterranean Diet-like advice through monthly individual counseling for 12 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes, vegetable oils, and locally sourced assorted fruit and vegetables for 18 months; (2) control arm with portion-control standard non-tailored nutritional counseling in monthly individual sessions for 12 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18-24, we will monitor behavior maintenance (no food/voucher or counseling), with support from the nutritionist, and cues-to-action texts. Investigators will measure changes in cardiometabolic risk factors and metrics of eating behaviors and psychological factors. The two co-primary outcomes are changes in ASCVD score and cardiometabolic improvement score.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Natalia Torres, BS
- Numéro de téléphone: 787-523-1593
- E-mail: natalia.torres@prcci.org
Lieux d'étude
-
-
-
San Juan, Porto Rico, 00926
- Recrutement
- Puerto Rico Consortium for Clinical Investigation
-
Contact:
- Natalia Torres, BS
- Numéro de téléphone: 787-523-1593
- E-mail: natalia.torres@prcci.org
-
Sous-enquêteur:
- Amarilys F Sylva, PhD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
-
Age 30-65y old at the time of enrollment
-
Non-institutionalized
-
Living in PR at the time of recruitment and for at least the previous year and not planning to move from the island within the next 3 years
-
Able to answer questions without assistance
-
Having a cellphone with the capacity to receive text messages and be willing to receive daily text messages from the study on the designated cellphone number
-
Having at least one of the following:
- elevated BMI
- elevated waist circumference
- self-reported physician-diagnosed hypertension or use of hypertension medication or measured high blood pressure at the baseline visit
- self-reported physician-diagnosed pre-diabetes or measured pre-diabetes at the baseline visit
- self-reported physician-diagnosed dyslipidemia or use of lipid-lowering agents or laboratory values confirming dyslipidemia
Exclusion Criteria:
- Under 30 or over 65 years of age (on the day of the interview).
- Currently not living in Puerto Rico or not lived on the island for at least 1 year or planning to move within 3 years
- Institutionalized
- Not able to answer questions without assistance
- Not having at least 1 of the five listed metabolic criteria
- Self-reported physician-diagnosed type 1 or type 2 diabetes or use of diabetes medication (including insulin) or diabetes-diagnosis values confirmed by laboratory
- Self-reported pregnancy
- Gastrointestinal or chronic condition that would impact eating behaviors or nutritional status
- Intolerance or allergies to legumes (i.e.: beans and nuts), vegetable oils (i.e.: corn, olive, canola), or fresh produce
- Living with another person participating in the study
- Participating in another research study that conflicts with PRECISION
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Intervention
Intervention group will receive culturally-tailored portion-control Mediterranean-like advice through monthly individual counseling for 6 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes (i.e., beans and peanuts), vegetable oils (i.e., olive oil + a blend of canola and soybean), and locally sourced assorted fruit and vegetables for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no food or counseling) with support from the nutritionist available. |
Puerto Rico-tailored education includes strategies for healthy eating, preferences for traditional healthy foods, recommendations for limiting unhealthy traditional foods, portion sizes, etc. |
|
Comparateur actif: Control
Control group will receive portion-control standard non-tailored nutritional counseling in monthly individual sessions for 6 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no voucher or counseling), with support from the nutritionist available. |
Standard healthy eating education includes strategies, foods, portions, and cooking and eating tips included in the My Plate For A Healthy Puerto Rico dietary recommendations. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
10-year risk score for a first atherosclerotic CVD event (ASCVD score)
Délai: 6; 12; 18; 24 months
|
Estimate the change in first atherosclerotic CVD event (ASCVD) score; the score is calculated using the Pooled Cohort Equation which accounts for biological sex, age, race, total cholesterol, HDL-C, systolic blood pressure, treatment for high blood pressure, current diabetes diagnosis, and smoking status. Scores are expressed as percentage (0-100) with higher scores indicative of higher 10-year risk for ASCVD event. It is categorized as low-risk <5%; borderline risk 5% to 7.4%; intermediate risk 7.5% to 19.9%; and high risk ≥20%. |
6; 12; 18; 24 months
|
|
Cardiometabolic Improvement Score (CIS)
Délai: 6; 12; 18; 24 months
|
Estimate the change in the score; calculated as the added number of risk factors changed over a predefined value; range of 0 to 10; from less to more improvement. |
6; 12; 18; 24 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in diet quality score
Délai: 6; 12; 18; 24 months
|
Determine the change in score of short diet quality screener (range 18-54; from lowest to highest quality) |
6; 12; 18; 24 months
|
|
Changes in diet satisfaction: diet satisfaction scale
Délai: 6; 12; 18; 24 months
|
Determine the change in the score of the Diet Satisfaction Questionnaire (DSat-45) (range 45-225; from lowest to highest satisfaction) and its summed seven subscales (ranges 5-40) |
6; 12; 18; 24 months
|
|
Changes in intake of pre-specified food groups (fruit; vegetables; legumes; oils; meat; fat)
Délai: 6; 12; 18; 24 months
|
Determine the change in servings/week of food groups |
6; 12; 18; 24 months
|
|
Change in levels of waist circumference
Délai: 6; 12; 18; 24 months
|
Estimate the change in the value of waist circumference (cm) |
6; 12; 18; 24 months
|
|
Change in levels of BMI
Délai: 6; 12; 18; 24 months
|
Estimate the change in the value of body mass index (kg/m2) |
6; 12; 18; 24 months
|
|
Change in levels of blood pressure risk factors
Délai: 6; 12; 18; 24 months
|
Estimate the change in the value of systolic and diastolic blood pressure (mmHg) |
6; 12; 18; 24 months
|
|
Change in levels of metabolic risk factors
Délai: 6; 12; 18; 24 months
|
Estimate the change in the value of glucose, triglycerides, total cholesterol, LDL, HDL (mg/dL) |
6; 12; 18; 24 months
|
|
Change in food security status
Délai: 6; 12; 18; 24 months
|
Estimate the change in food security status assessed by the USDA Food Security Module |
6; 12; 18; 24 months
|
|
Change in self-efficacy score
Délai: 6; 12; 18; 24 months
|
Estimate the change in self-efficacy score assessed by the Nutritional Self-Efficacy Scale |
6; 12; 18; 24 months
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in social connectedness score
Délai: 6; 12; 18; 24 months
|
Estimate the change in social connectedness score from the Social Connectedness Scale/Social Assurance Scale |
6; 12; 18; 24 months
|
|
Change in social support score
Délai: 6; 12; 18; 24 months
|
Estimate the change in social support score from the 12-item Social Support Scale |
6; 12; 18; 24 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Josiemer Mattei, PhD, MPH, Harvard Chan School of Public Health
- Directeur d'études: Amarilys F Sylva, PhD, Puerto Rico Consortium for Clinical Investigations
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies du système endocrinien
- Maladies vasculaires
- Maladies cardiovasculaires
- Troubles nutritionnels
- Maladies métaboliques
- Suralimentation
- Poids
- Troubles du métabolisme du glucose
- Diabète sucré
- En surpoids
- Hyperlipidémies
- Troubles du métabolisme lipidique
- Conditions pathologiques, signes et symptômes
- Maladies nutritionnelles et métaboliques
- Signes et symptômes
- Obésité
- Hypertension
- Diabète sucré, Type 2
- Hyperglycémie
- Dyslipidémies
- Hypertriglycéridémie
- Obésité abdominale
- Qualité des soins de santé, accès et évaluation
- Techniques d'investigation
- Méthodes épidémiologiques
- Collecte de données
- Mécanismes d'évaluation des soins de santé
- Qualité des soins de santé
- Santé publique
- Environnement et santé publique
- Mesures épidémiologiques
- Évaluation nutritionnelle
Autres numéros d'identification d'étude
- IRB23-0951
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
IPD will be managed and distributed observing NIH and IRB policies on the dissemination and sharing of research results. Study information and requests for data will be available immediately upon the data being de-identified and properly revised for quality control by contacting study investigators.
Délai de partage IPD
10 years
Critères d'accès au partage IPD
The requested data will be shared with investigators via a secured, password-protected software website, upon request.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- CIF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .